{"id":30912,"date":"2021-12-19T09:37:00","date_gmt":"2021-12-19T09:37:00","guid":{"rendered":"https:\/\/haberglobal.com.tr\/gundem\/yerli-koronavirus-asisi-turkovacta-on-sonuclar-belli-oldu-149714"},"modified":"2021-12-19T09:37:00","modified_gmt":"2021-12-19T09:37:00","slug":"yerli-koronavirus-asisi-turkovacta-on-sonuclar-belli-oldu","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/12\/19\/yerli-koronavirus-asisi-turkovacta-on-sonuclar-belli-oldu\/","title":{"rendered":"Yerli koronavir\u00fcs a\u015f\u0131s\u0131 Turkovac’ta \u00f6n sonu\u00e7lar belli oldu!"},"content":{"rendered":"

<\/p>\n

\n
\n

Yay\u0131nlanma: <\/span>

<\/p>\n
\"Yerli <\/picture> <\/figure>\n

<\/a> <\/div>\n<\/p><\/div>\n

\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131<\/a> Koronavir\u00fcs<\/a> Bilim Kurulu \u00dcyesi Prof. Dr. Ate\u015f Kara, acil kullan\u0131m onay\u0131 ba\u015fvurusu yap\u0131lan yerli inaktif Covid-19 a\u015f\u0131s\u0131 Turkovac’la ilgili y\u00fcr\u00fct\u00fclen klinik \u00e7al\u0131\u015fmalarda elde edilen \u00f6n sonu\u00e7lar\u0131 de\u011ferlendirdi.<\/p>\n

TURKOVAC a\u015f\u0131s\u0131n\u0131n klinik \u00e7al\u0131\u015fmalardaki verilerinin olduk\u00e7a olumlu oldu\u011funu, inaktif a\u015f\u0131 Sinovac’la y\u00fcr\u00fct\u00fclen kar\u015f\u0131la\u015ft\u0131rmal\u0131 verilerden de olumlu sonu\u00e7lar al\u0131nd\u0131\u011f\u0131n\u0131 belirten Kara, Turkovac’la ilgili iki grup veri \u00fczerinden de\u011ferlendirme yap\u0131ld\u0131\u011f\u0131n\u0131 anlatt\u0131.<\/p>\n

“\u0130LK VER\u0130LER\u0130M\u0130Z \u00c7OK OLUMLU”<\/h2>\n

Kara, bu kapsamda ilk olarak yerli a\u015f\u0131n\u0131n etkinli\u011finin saptanmas\u0131na i\u00e7in bir gruba Turkovac, di\u011fer gruba da mevcut kullan\u0131lan a\u015f\u0131n\u0131n uyguland\u0131\u011f\u0131n\u0131 ifade ederek, \u015fu bilgileri payla\u015ft\u0131:<\/p>\n

“\u015eu ana kadar elde etti\u011fimiz verilerde, Turkovac uygulanan ki\u015filer aras\u0131nda a\u011f\u0131r hastalanan, hastaneye veya yo\u011fun bak\u0131ma yatan olmad\u0131\u011f\u0131n\u0131 g\u00f6rd\u00fck. Ayr\u0131ca di\u011fer a\u015f\u0131n\u0131n uyguland\u0131\u011f\u0131 grupta da \u00e7ok a\u011f\u0131r hastalanan olmad\u0131. Covid-19 pozitif olanlar\u0131n say\u0131lar\u0131n\u0131 kar\u015f\u0131la\u015ft\u0131rd\u0131\u011f\u0131m\u0131zda da Turkovac’da avantajl\u0131 oldu\u011fumuzu g\u00f6r\u00fcyoruz. Bu, a\u015f\u0131n\u0131n etkinli\u011fini, koruyuculu\u011funu g\u00f6sterme y\u00f6n\u00fcnden bir avantaj. Bu noktada ilk verilerimiz \u00e7ok olumlu. Bu verilerin hepsi, detaylar\u0131yla acil kullan\u0131m onay\u0131n\u0131 de\u011ferlendiren komisyonlara sunuldu. \u00c7ok titiz de\u011ferlendiriliyor.”<\/p>\n

A\u015eININ YAN ETK\u0130LER\u0130YLE \u0130LG\u0130L\u0130 \u0130LK SONU\u00c7LAR DA OLUMLU<\/h2>\n

A\u015f\u0131n\u0131n yan etkilerinin ele al\u0131nd\u0131\u011f\u0131, g\u00fcvenlik y\u00f6n\u00fcyle ilgili ikinci grup \u00e7al\u0131\u015fmada ise yakla\u015f\u0131k 3-4 bin ki\u015fiye ula\u015f\u0131lmas\u0131n\u0131n ama\u00e7land\u0131\u011f\u0131na dikkati \u00e7eken Kara, “Bu noktada ba\u015flang\u0131ca g\u00f6re bir avantaj\u0131m\u0131z var; inaktif a\u015f\u0131lar genel anlamda kullan\u0131ld\u0131\u011f\u0131 ve d\u00fcnya genelinde yakla\u015f\u0131k 3,5 milyar ki\u015fiye uyguland\u0131\u011f\u0131 i\u00e7in olas\u0131 istenmeyen etkilerinin neler ve hangi s\u0131kl\u0131kta oldu\u011funu biliyoruz. Turkovac’ta da bu etkilerin g\u00f6r\u00fcl\u00fcp g\u00f6r\u00fclmedi\u011fine bak\u0131yoruz. O verilerin de olumlu oldu\u011funu g\u00f6rd\u00fck.” dedi.<\/p>\n

Kara, bu iki grup verinin acil kullan\u0131m onay\u0131 s\u00fcrecinde avantaj sa\u011flayan sonu\u00e7lardan oldu\u011funa dikkati \u00e7ekti.<\/p>\n

\u00c7OK SAYIDA TEST UYGULANIYOR<\/h2>\n

Bilim Kurulu \u00dcyesi Prof. Dr. Kara, a\u015f\u0131n\u0131n \u00fcretim a\u015famas\u0131na y\u00f6nelik de \u00e7ok say\u0131da test uyguland\u0131\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7izerek, Turkovac’\u0131n \u00fcretilebilir oldu\u011funun saptand\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n

Ayr\u0131ca \u00fcretim s\u00fcrecinde a\u015f\u0131n\u0131n antijen miktar\u0131n\u0131n v\u00fccut a\u00e7\u0131s\u0131ndan yeterli olup olmad\u0131\u011f\u0131 ve son kullanma tarihinin belirlenmesine ili\u015fkin, “stabilite” testlerinin yap\u0131ld\u0131\u011f\u0131n\u0131 anlatan Kara, Turkovac’\u0131n onay almas\u0131 durumunda \u00fczerine “3 ayl\u0131k kullan\u0131m s\u00fcresi vard\u0131r” diye yaz\u0131labilece\u011fini ifade etti.<\/p>\n

Bu kullan\u0131m s\u00fcresinin periyodik olarak yap\u0131lacak stabilite testlerinden elde edilen sonu\u00e7lara g\u00f6re 6 aya \u00e7\u0131kabilece\u011fini aktaran Kara, birka\u00e7 y\u0131l s\u00fcrecek testler sonucunda da kullan\u0131m s\u00fcresinin 1 veya 2 y\u0131l olarak belirlenebilece\u011fini dile getirdi.<\/p>\n

Kara, a\u015f\u0131larla ilgili bu testlerin \u00e7ok titiz, “ki\u015fiyi en fazla nas\u0131l korurum” yakla\u015f\u0131m\u0131yla ger\u00e7ekle\u015ftirildi\u011finin alt\u0131n\u0131 \u00e7izdi.<\/p>\n

“HATIRLATMA DOZU OLARAK KULLANILAB\u0130L\u0130R “<\/h2>\n

Kara, Turkovac’\u0131n hat\u0131rlatma dozu olarak uygulanmas\u0131na y\u00f6nelik y\u00fcr\u00fct\u00fclen klinik \u00e7al\u0131\u015fman\u0131n bulgular\u0131na ili\u015fkin de \u015fu bilgileri payla\u015ft\u0131:<\/p>\n

“\u0130naktif ve mRNA a\u015f\u0131lar\u0131nda ilk iki dozdan sonra uygulanan hat\u0131rlatma dozuyla, antikor seviyesinde h\u0131zl\u0131 bir z\u0131plama g\u00f6r\u00fcl\u00fcyor. Turkovac’\u0131n hat\u0131rlatma dozu olarak uyguland\u0131\u011f\u0131 \u00e7al\u0131\u015fmalarda da b\u00f6yle bir z\u0131plamay\u0131 g\u00f6r\u00fcyoruz. Bu da bizim en b\u00fcy\u00fck avantajlar\u0131m\u0131zdan bir tanesi. Veriler, a\u015f\u0131n\u0131n hat\u0131rlatma dozu olarak kullan\u0131labilir olaca\u011f\u0131n\u0131 g\u00f6steriyor.”<\/p>\n

Kara, bu sonu\u00e7lar\u0131 bir ara\u015ft\u0131rmac\u0131 olarak yorumlad\u0131\u011f\u0131na dikkati \u00e7ekerek, esas \u00e7ok y\u00f6nl\u00fc de\u011ferlendirmenin Turkovac’\u0131n acil kullan\u0131m s\u00fcrecini inceleyen ba\u011f\u0131ms\u0131z ve tarafs\u0131z komisyondaki hocalar taraf\u0131ndan yap\u0131laca\u011f\u0131n\u0131 ve bunun sonucunda bir karara var\u0131laca\u011f\u0131n\u0131 vurgulad\u0131.<\/p>\n

AC\u0130L KULLANIM ONAYI ALMASI G\u00dcVEN\u0130L\u0130R OLDU\u011eUNU KANITLAYACAK<\/h2>\n

Komisyonun bu kapsaml\u0131 de\u011ferlendirmeleri sonucunda Turkovac’a acil kullan\u0131m onay\u0131 verilmesinin a\u015f\u0131n\u0131n her y\u00f6n\u00fcyle g\u00fcvenilir oldu\u011fu anlam\u0131na gelece\u011fine i\u015faret eden Kara, \u015funlar\u0131 kaydetti:<\/p>\n

“Yap\u0131lan incelemelerde \u00fcretiminin, istenmeyen etkilerinin, etkinli\u011finin ‘uygun’ \u015feklinde de\u011ferlendirilmesi durumunda, \u015fu an nas\u0131l \u00fclkemizde istenirse mRNA, istenirse inaktif Sinovac a\u015f\u0131s\u0131 olunabiliyor, \u00fc\u00e7\u00fcnc\u00fc bir a\u015f\u0131 olarak Turkovac da rahatl\u0131kla kullan\u0131labilir olacak. \u0130steyen herkes Turkovac’\u0131 da a\u015f\u0131 dozu olarak tercih edebilecek.”<\/p>\n

Kaynak: AA<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Yerli inaktif koronavir\u00fcs a\u015f\u0131s\u0131 Turkovac’\u0131n klinik \u00e7al\u0131\u015fmalar\u0131ndan elde edilen \u00f6n verilere g\u00f6re, a\u015f\u0131n\u0131n uyguland\u0131\u011f\u0131 ki\u015filer aras\u0131nda koronavir\u00fcs\u00fc (Covid-19) a\u011f\u0131r ge\u00e7iren…<\/p>\n","protected":false},"author":2,"featured_media":30913,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,15],"tags":[],"class_list":["post-30912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-turkiye"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/30912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=30912"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/30912\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/30913"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=30912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=30912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=30912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}